Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PACS (PACS) Revenue: 2022-2024

Historic Revenue for PACS (PACS) over the last 3 years, with FY2024 value amounting to $4.1 billion.

  • PACS's Revenue rose 3101.05% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 billion, marking a year-over-year increase of 3758.44%. This contributed to the annual value of $4.1 billion for FY2024, which is 3143.96% up from last year.
  • PACS's Revenue amounted to $4.1 billion in FY2024, which was up 3143.96% from $3.1 billion recorded in FY2023.
  • In the past 5 years, PACS's Revenue ranged from a high of $4.1 billion in FY2024 and a low of $2.4 billion during FY2022
  • For the 3-year period, PACS's Revenue averaged around $3.2 billion, with its median value being $3.1 billion (2023).
  • As far as peak fluctuations go, PACS's Revenue soared by 2846.82% in 2023, and later skyrocketed by 3143.96% in 2024.
  • Annual analysis of 3 years shows PACS's Revenue stood at $2.4 billion in 2022, then increased by 28.47% to $3.1 billion in 2023, then soared by 31.44% to $4.1 billion in 2024.
  • Its Revenue stands at $4.1 billion for FY2024, versus $3.1 billion for FY2023 and $2.4 billion for FY2022.